MCAC Panel Recommends Coverage Decision Of Bilateral DBS For Parkinson’s
This article was originally published in The Gray Sheet
Executive Summary
Medicare coverage conditions for bilateral deep-brain stimulation to treat Parkinson's disease should stipulate that procedures be performed by a "specialized team" of movement-disorder neurologists and neurosurgeons, Medicare Coverage Advisory Committee panel members concluded June 12
You may also be interested in...
Activa Deep-Brain Stimulation Coverage Includes Provider, Facility Criteria
CMS will monitor results of two long-term clinical studies evaluating "optimal targeting" for deep-brain stimulation to treat Parkinson's disease and essential tremor, following a positive national coverage determination
Activa Deep-Brain Stimulation Coverage Includes Provider, Facility Criteria
CMS will monitor results of two long-term clinical studies evaluating "optimal targeting" for deep-brain stimulation to treat Parkinson's disease and essential tremor, following a positive national coverage determination
“Substantial” Device Effectiveness Proposed As Coverage Decision Category
CMS will allow the Medicare Coverage Advisory Committee to designate a new effectiveness category for devices showing a "substantial clinical benefit" over existing technologies, Acting Chief Clinical Officer Sean Tunis indicated Sept. 25